What Trimtech Therapeutics say about themselves
“Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates”
Trimtech Therapeutics Limited
- Incorporated
- 21 November 2023 (2 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Alison Frances Lawton
- Accounts type
- Small
- Region
- East of England
- Address
- Suite DBuilding 960Babraham Research CampusCambridgeCB22 3FH
Website & contact details
- Website
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 4 December 2026
- Last conf. stmt
- 20 November 2025
Charges
- Total
- 1
- Outstanding
- 1
- Part satisfied
- 0
- Satisfied
- 0
Officers 8 active
Officer details are public data from the Companies House register.
Director · Appointed 24 June 2026
Also at Dunad Therapeutics Ltd., Theolytics Ltd
British
Born October 1992 (34)
Russian
Born June 1992 (34)
Lawton, Alison Frances
Director · Appointed 20 November 2025
British,American
Born September 1961 (65)
Director · Appointed 19 February 2025
British
Born November 1975
Peakman, Marie-Claire
Director · Appointed 19 February 2025
British
Born July 1969 (57)
Director · Appointed 3 December 2024
British
Born September 1980 (46)
Director · Appointed 3 December 2024
British
Born June 1972 (54)
Thompson, Nicola
Director · Appointed 27 February 2024
British
Born April 1964 (62)
Officer history (2 former)
1 July 2026
Resigned Moore, Jeffrey Bernard as Director
24 June 2026
24 June 2026
20 November 2025
Appointed Lawton, Alison Frances as Director
19 February 2025
19 February 2025
Appointed Peakman, Marie-Claire as Director
4 December 2024
3 December 2024
3 December 2024
3 December 2024
Appointed Moore, Jeffrey Bernard as Director
27 February 2024
Appointed Thompson, Nicola as Director
21 November 2023
Ownership 0 active
People and entities with significant control, from the Companies House PSC register
The company has declared that it has no person with significant control.
Former controllers (2)
3 December 2024
Ceased Leo James — Owns 25–50% of shares
3 December 2024
Ceased William Alexander Mcewan — Owns 25–50% of shares
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Net Assets
- £5,631,059
- Employees
- 1
- Debt Ratio
- 4%
- Current Ratio
- 30.3x
Balance sheet detail
| 2024 | |
|---|---|
| Fixed Assets | £10,216 |
| Current Assets | £5,825,208 |
| Creditors (< 1 year) | £191,987 |
| Net Current Assets | £5,736,337 |
| Net Assets | £5,631,059 |
| Shareholder Funds | £5,631,059 |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 3 August 2026 | Other filing | |||
| 23 July 2026 | Replacement filing for the appointment of a director | |||
| 23 July 2026 | Replacement filing for the appointment of a director | |||
| 14 July 2026 | Accounts for a small company | 31 December 2025 | ||
| 13 July 2026 | Memorandum and Articles of Association |
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →